CIK 0001682852 · Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 813467528
- Phone
- 6177146500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,875,818
- in 4 filings, $33.9M under 10b5-1 plans
Net −$33,875,818. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-27 | Hoge Stephen President | Shares withheld for taxes | −695 | $47.03 | $33K | 1,478,739 |
| 2026-05-27 | Hoge Stephen President | Option exercise · Restricted Stock Units | −1,437 | 10,058 | ||
| 2026-05-21 | AFEYAN NOUBAR Director | Option exercise | +9,263 | $19.15 | $177K | 13,187 |
| 2026-05-21 | AFEYAN NOUBAR Director | Sale | −9,263 | $46.84 | $434K | 3,924 |
| 2026-05-21 | AFEYAN NOUBAR Director | Option exercise · Stock Option (Right to Buy) | −9,263 | 0 | ||
| 2026-05-15 | Hoge Stephen President | Option exercise 10b5-1 | +37,226 | $19.15 | $713K | 1,515,223 |
| 2026-05-15 | Hoge Stephen President | Option exercise 10b5-1 | +16,110 | $19.15 | $309K | 1,531,333 |
| 2026-05-15 | Hoge Stephen President | Sale 10b5-1 | −53,336 | $48.40 | $2.6M | 1,477,997 |
| 2026-05-15 | Hoge Stephen President | Option exercise · Stock Option (Right to Buy) 10b5-1 | −37,226 | 74,452 | ||
| 2026-05-15 | Hoge Stephen President | Option exercise · Stock Option (Right to Buy) 10b5-1 | −16,110 | 32,220 | ||
| 2026-05-06 | Rubenstein David M. Director | Grant or award · Stock Option (Right to Buy) | +9,681 | 9,681 | ||
| 2026-05-06 | Rubenstein David M. Director | Grant or award · Restricted Stock Units | +2,092 | 2,092 | ||
| 2026-05-06 | Hussain Abbas Director | Grant or award · Restricted Stock Units | +8,371 | 8,371 | ||
| 2026-05-06 | Horning Sandra Director | Grant or award · Stock Option (Right to Buy) | +9,681 | 9,681 | ||
| 2026-05-06 | Horning Sandra Director | Grant or award · Restricted Stock Units | +2,092 | 2,092 | ||
| 2026-05-06 | NABEL ELIZABETH G Director | Grant or award · Restricted Stock Units | +8,371 | 8,371 | ||
| 2026-05-06 | Nader Francois Director | Grant or award · Stock Option (Right to Buy) | +6,454 | 6,454 | ||
| 2026-05-06 | Nader Francois Director | Grant or award · Restricted Stock Units | +4,185 | 4,185 | ||
| 2026-05-06 | Tallett Elizabeth E Director | Grant or award · Restricted Stock Units | +8,371 | 8,371 | ||
| 2026-05-06 | AFEYAN NOUBAR Director | Grant or award · Stock Option (Right to Buy) | +12,908 | 12,908 |
Page 7 of 20 · 389 trades